mir-146a and mir-155 expression levels in acute graft-Versus-host Disease incidence
mir-146a and mir-155 expression levels in acute graft-Versus-host Disease incidence
复制标题
mir-146a 和 mir-155 在急性移植物抗宿主病发病率中的表达水平
DOI:
10.3389/fimmu.2016.00056
复制
发表时间:
2016-03-08
影响因子:
7.3
通讯作者:
Dickinson, Anne Mary
中科院分区:
文献类型:
--
作者:
Atarod, Sadaf;Ahmed, Mohammed Mahid;Dickinson, Anne Mary
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for numerous hematological malignancies. However, acute graft-versus-host disease (aGVHD) is still the major complication causing mortality. MicroRNAs (miRNAs) play a significant role in inflammation and have potential as prognostic and diagnostic biomarkers. This study investigated the role of two immune-specific miRNAs (miR-146a and miR-155) as biomarkers for aGVHD incidence in the peripheral blood of allo-HSCT patients prior to disease onset. The study showed that miR-146a and its statistical interaction with miR-155 at day +28 were predictive of aGVHD incidence. Interestingly, the expression levels of miR-146a and miR-155 negatively correlated with the transcription factor, SPI1 (PU.1gene) mRNA expression.